Company: PTPI
Filing Date: 2025-02-19
Form Type: 424B4
Source: 0001410578-25-000164
Chunk: 171

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-19
Form: 424B4
Chunk 171
---
 the Company’s industry and should not be construed as an alternative to net sales as an indicator of operating performance (as determined in accordance with GAAP). The Company’s presentation of gross billings may not be comparable to similarly titled measures reported by other companies. Gross billings is adjusted to exclude certain items that affect comparability. The adjustments are itemized in the tables below. You are encouraged to evaluate these adjustments and the reason the Company considers them appropriate for supplemental analysis. In evaluating adjustments, you should be aware that in the future the Company may incur expenses that are the same as or similar to some of the adjustments set forth below. The presentation of these adjustments should not be construed as an inference that future results will be unaffected by unusual or recurring items. The Company defines gross billings as the amount of its aggregate sales billed to customers at standard prices before the application of certain adjustments that reduce the net amount received from customers, including product returns, certain rebates and coupon redemptions, discounts and fees. The following table presents a reconciliation of net sales to gross billings for the years ended December 31, 2023, and 2022.

| ​                         | ​ 
 ​ | For the Year Ended |            | ​ |      |            | ​ 
 ​ |
|:--------------------------|:--|-------------------:|-----------:|:--|-----:|-----------:|:--|
| ​                         | ​ |       December 31, |            |   |      |            | ​ |
| ​                         |   |               2023 |            |   | 2022 |            |   |
| Net Sales                 | ​ |                  $ |  5,822,388 | ​ |    $ |  5,992,054 | ​ |
| Product Returns           | ​ |                  ​ |  3,381,694 | ​ |    ​ |  9,355,121 | ​ |
| Contract Rebates          | ​ |                  ​ |  1,451,441 | ​ |    ​ |  1,685,080 | ​ |
| Chargebacks               | ​ |                  ​ |    157,877 | ​ |    ​ |    164,577 | ​ |
| Cash Discounts            | ​ |                  ​ |    157,568 | ​ |    ​ |    319,630 | ​ |
| Distribution Service Fees | ​ |                  ​ |    879,780 | ​ |    ​ |  1,